$28.35
0.28%
Nasdaq, Fri, Oct 02 2026.
ISIN
US81728A1088
Symbol
SNSE

Sensei Biotherapeutics Inc Stock price

$28.35
-10.77 27.53% 1M
-2.67 8.61% 6M
+17.68 165.70% YTD
+18.95 201.60% 1Y
+13.35 89.00% 3Y
-168.05 85.57% 5Y
-351.65 92.54% 10Y
-351.65 92.54% 20Y
Nasdaq, Closing price Fri, Oct 02 2026
+0.08 0.28%
ISIN
US81728A1088
Symbol
SNSE
Industry

Is Sensei Biotherapeutics Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.

Key metrics

Basic
Market capitalization
-
Enterprise Value
-
Net debt
positive
Cash
$202.8m
Shares outstanding
1.3m
Valuation
P/E
negative
P/S | estimate
- | -
EV/Sales | estimate
- | -
EV/FCF | ex SBC
- | -
P/B
-
Financial Health
Equity Ratio
81.2%
Return on Equity
-113.4%
ROCE
-27.6%
ROIC
5,431.3%
Debt/Equity
0.0
Share-Based Compensation & Dilution
SBC | % of Revenue
$13.7m | -
SBC as % of FCF
-
SBC Growth 1Y
476.1%
Share Count Growth 1Y
6.3%
Shareholder Yield
-6.3%
Financials
Revenue | estimate
$0.0 | $0.0
EBITDA
$-52.6m
EBIT
$-52.7m
Net Income
$-184.5m
Free Cash Flow | ex SBC
$-24.1m | $-37.8m
Growth
Revenue | estimate
- | -
EBITDA
-74.4%
EBIT
-69.1%
Net Income
-535.4%
Free Cash Flow
0.6%
Margin
Gross
-
EBITDA
-
EBIT
-
Net
-
Free Cash Flow | ex SBC
- | -
More
EPS
$-142.4
FCF per Share
$-18.0
Short interest
84.6%
Employees
15
Rev per Employee
$0.0

Sensei Biotherapeutics Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Sensei Biotherapeutics Inc forecast:

8x Buy
80%
2x Hold
20%

Analyst Opinions

10 Analysts have issued a Sensei Biotherapeutics Inc forecast:

Buy
80%
Hold
20%

Financial data from Sensei Biotherapeutics Inc

Mar '26
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 27 27
115% 115%
-
- Research and Development Expense 25 25
44% 44%
-
-53 -53
74% 74%
-
- Depreciation and Amortization 0.14 0.14
86% 86%
-
EBIT (Operating Income) EBIT -53 -53
69% 69%
-
Net Profit -184 -184
535% 535%
-

In millions USD.

Don't miss a Thing! We will send you all news about Sensei Biotherapeutics Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Sensei Biotherapeutics Inc Stock News

Neutral
Business Wire
●
4 months ago
AUSTIN, Texas--(BUSINESS WIRE)--Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today announced that it has changed its corporate name to Faeth Therapeutics, Inc. (the “Company”). The Company's common stock is expected to begin trading on the Nasdaq Capital Market under the new ticker symbol “FTH” on June 16, 2026, and the Company has launched a new corporate website at www.faeththerapeutics.com. O...
Neutral
Business Wire
●
4 months ago
BOSTON--(BUSINESS WIRE)--Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today announced that, effective on June 1, 2026, the Compensation Committee of Sensei's Board of Directors granted three new employees options to purchase an aggregate of 19,300 shares of the Company's common stock in connection with their employment (collectively, the “Option Awards”). The Option Awards were granted pursuant ...
Neutral
Business Wire
●
5 months ago
BOSTON--(BUSINESS WIRE)--Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today reported financial results for the first quarter ended March 31, 2026, and provided a corporate update. “The first quarter of 2026 was transformational for the Company, with the acquisition of Faeth Therapeutics and the concurrent $200 million private placement in February, supported by a group of leading life sciences i...
More Sensei Biotherapeutics Inc News

Company Profile

Sensei Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company which focuses on the discovery, development, and delivery of next generation of immunotherapies for the treatment of cancer and infectious diseases. The company was founded in 1999 and is headquartered in Rockville, MD.

Head office United States
CEO Mr. Gerry
Employees 15
Founded 1999
Website www.senseibio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today